These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10092689

  • 21. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH, Walters JA, Gibson MD.
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [Abstract] [Full Text] [Related]

  • 22. Managing symptoms and exacerbations in pediatric asthma.
    Verberne AA.
    Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
    [Abstract] [Full Text] [Related]

  • 23. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409
    [Abstract] [Full Text] [Related]

  • 24. Medicaid's beta 2-agonist recipients and their treatment by national standards.
    Reddy P, Kelly ET, Kophazi ME, Geary EA, Markelon JD, Welter KJ.
    Ann Pharmacother; 2001 Jun 19; 35(6):682-6. PubMed ID: 11408984
    [Abstract] [Full Text] [Related]

  • 25. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM, Lipworth B.
    Drug Saf; 2004 Jun 19; 27(4):243-70. PubMed ID: 15003036
    [Abstract] [Full Text] [Related]

  • 26. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ, Taylor DR.
    BioDrugs; 2001 Jun 19; 15(1):11-24. PubMed ID: 11437672
    [Abstract] [Full Text] [Related]

  • 27. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A.
    N Engl J Med; 1997 Nov 13; 337(20):1405-11. PubMed ID: 9358137
    [Abstract] [Full Text] [Related]

  • 28. A survey on the diagnosis and management of asthma in young children.
    Kourdoulos D, Schattner P.
    Aust Fam Physician; 1997 Jul 13; 26 Suppl 2():S71-5. PubMed ID: 9254945
    [Abstract] [Full Text] [Related]

  • 29. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada.
    Lynd LD, Guh DP, Paré PD, Anis AH.
    Chest; 2002 Dec 13; 122(6):1973-81. PubMed ID: 12475835
    [Abstract] [Full Text] [Related]

  • 30. Interactions between corticosteroids and beta2-agonists.
    Hancox RJ.
    Clin Rev Allergy Immunol; 2006 Dec 13; 31(2-3):231-46. PubMed ID: 17085796
    [Abstract] [Full Text] [Related]

  • 31. Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment.
    Walters EH, Walters J.
    Cochrane Database Syst Rev; 2003 Dec 13; (2):CD001285. PubMed ID: 12804401
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological management of children's asthma in general practice: findings from a community-based cross-sectional survey in Auckland, New Zealand.
    Crengle S, Robinson E, Grant C, Arroll B.
    N Z Med J; 2011 Nov 25; 124(1346):44-56. PubMed ID: 22143852
    [Abstract] [Full Text] [Related]

  • 33. [Update on current care guidelines: asthma].
    Haahtela T, Lehtimäki L, Ahonen E, Harju T, Jartti T, Kankaanranta H, Korhonen K, Mäkelä M, Puurunen M, Sovijärvi A, Valovirta E, Venho KK.
    Duodecim; 2013 Nov 25; 129(9):994-5. PubMed ID: 23786112
    [Abstract] [Full Text] [Related]

  • 34. Validity of performance indicators for assessing prescribing quality: the case of asthma.
    Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM.
    Eur J Clin Pharmacol; 2004 Jan 25; 59(11):833-40. PubMed ID: 14624323
    [Abstract] [Full Text] [Related]

  • 35. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
    Barthwal MS, Deoskar RB, Rajan KE.
    J Assoc Physicians India; 2005 Aug 25; 53():681-4. PubMed ID: 16398075
    [Abstract] [Full Text] [Related]

  • 36. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R, Guest JF.
    Pharmacoeconomics; 2003 Aug 25; 21(5):357-69. PubMed ID: 12627989
    [Abstract] [Full Text] [Related]

  • 37. Asthma update: Part II. Medical management.
    Mintz M.
    Am Fam Physician; 2004 Sep 15; 70(6):1061-6. PubMed ID: 15456115
    [Abstract] [Full Text] [Related]

  • 38. Assessment of asthma control: the SERENA study.
    Corrado A, Renda T, Polese G, Rossi A, SERENA (Studio ossERvazionalE per il monitoraggio dell'asma non coNtrollAto)/AIPO Study Group.
    Respir Med; 2013 Nov 15; 107(11):1659-66. PubMed ID: 24045118
    [Abstract] [Full Text] [Related]

  • 39. Asthma: 1987-2007. What have we achieved and what are the persisting challenges?
    Partridge MR.
    Prim Care Respir J; 2007 Jun 15; 16(3):145-8. PubMed ID: 17530142
    [Abstract] [Full Text] [Related]

  • 40. [Use of drugs for CNSLD (asthma and COPD) in Dutch residential homes and nursing homes].
    Offerhaus MP, Haan IB, Herijgers DC, Cools HJ.
    Tijdschr Gerontol Geriatr; 1997 Jun 15; 28(3):101-5. PubMed ID: 9381517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.